Plasmapheresis Market Size, Share, Growth Analysis, By Product (Instruments, Disposables), By Technology (Membrane Filtration, Centrifugation), By Procedure, By Application, By End User, By Region - Industry Forecast 2025-2032

Plasmapheresis Market size was valued at USD 1.24 Billion in 2023 and is poised to grow from USD 1.34 Billion in 2024 to USD 2.41 Billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The global plasmapheresis industry is poised for significant growth due to a variety of macroeconomic and microeconomic factors. Increased healthcare spending, particularly in the Middle East and Asia-Pacific regions, is driving a greater focus on advanced medical therapies. Additionally, heightened awareness of treatment options for immune system disorders such as myasthenia gravis and lupus is expected to fuel market demand. Projections indicate a growth of approximately 79 basis points from 2022 to 2028, with the market catering to over 35.9% of the autoimmune disease diagnostics sector, which is estimated to grow at a 21.1% CAGR. The market experienced a 4.6% CAGR increase to reach USD 1.2 billion by the end of 2021 and is anticipated to reach USD 1.3 billion, with North America leading the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Plasmapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Plasmapheresis Market Segmental Analysis

Global Plasmapheresis Market is segmented by product, technology, procedure, application, end user and region. Based on product, the market is segmented into instruments and disposables. Based on technology, the market is segmented into membrane filtration and centrifugation. Based on procedure, the market is segmented into photopheresis, Ldl apheresis, plateletpheresis, leukapheresis and erythrocytapheresis. Based on application, the market is segmented into source plasma collection, therapeutic plasmapheresis, immunology, neurology, hematology, critical care, oncology, rheumatology & orthopedics and other therapeutic applications. Based on end user, the market is segmented into blood banks & plasma collection centers, hospital & clinics, biopharmaceutical companies and other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Plasmapheresis Market

The plasmapheresis market is poised for growth, largely driven by its critical role in managing a range of autoimmune disorders, including thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. As the prevalence of these conditions rises, so does the demand for plasmapheresis equipment. Additionally, increasing awareness among end-users and a heightened focus on enhancing healthcare infrastructure are anticipated to propel market expansion. The growing healthcare investments in regions such as the Middle East, Africa, and Asia Pacific are further expected to drive the adoption of advanced treatment methods, thereby boosting the plasmapheresis industry during the forecast period.

Restraints in the Plasmapheresis Market

The plasmapheresis market faces certain restraints primarily due to concerns regarding adverse effects associated with the procedure. Although these side effects, which can include decreased arterial blood pressure, arrhythmias, transient increases in body temperature, and paresthesia, are generally mild, they can still deter potential patients from opting for this therapy. Consequently, these safety concerns may hinder the overall adoption of plasmapheresis, impacting its growth in the market. As such, market players could experience challenges during the evaluation period due to a decline in the utilization of plasmapheresis as a viable treatment option, affecting their overall market performance.

Market Trends of the Plasmapheresis Market

The plasmapheresis market is poised for significant growth, fueled by the escalating demand for effective treatments for various ailments including anemia, blood disorders, and autoimmune diseases. Innovations in apheresis technology, driven by advancements in healthcare infrastructure and increased investments in research and development, are enhancing the efficiency and safety of plasmapheresis procedures. Furthermore, the rising awareness of the therapeutic benefits of plasma exchange therapies is catalyzing a surge in blood donation rates. As healthcare organizations focus on optimizing plasmapheresis equipment worldwide, the market is expected to expand robustly in the coming years, driven by these pivotal trends and advancements.